Viewing Study NCT01955694


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-02-23 @ 1:13 AM
Study NCT ID: NCT01955694
Status: COMPLETED
Last Update Posted: 2021-07-16
First Post: 2013-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BAY94-8862 View
None MR antagonist View
None Heart failure View
None Japanese patients View